Nuo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nuo Therapeutics's estimated annual revenue is currently $3.3M per year.
- Nuo Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Nuo Therapeutics has 21 Employees.
- Nuo Therapeutics grew their employee count by -12% last year.
Nuo Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Chief Financial Officer | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | Regional Sales Director ~West | Reveal Email/Phone |
4 | Customer Service Manager | Reveal Email/Phone |
5 | Corporate Services Manager | Reveal Email/Phone |
6 | CSO/COO | Reveal Email/Phone |
7 | Marketing Consultant | Reveal Email/Phone |
Nuo Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Nuo Therapeutics?
Nuo Therapeutics, Inc. (formerly Cytomedix, Inc.) is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers (bedsores).
keywords:N/AN/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 21 | N/A | N/A |
#2 | $2.1M | 21 | -16% | N/A |
#3 | $1.8M | 21 | N/A | N/A |
#4 | $2.3M | 23 | -8% | N/A |
#5 | $2.3M | 23 | -26% | N/A |